Biomedical Engineering Reference
In-Depth Information
bonding cooperatively confer a van-
comycin hydrogel: a potential candidate
for biomaterials.
J. Am. Chem. Soc.
,
Lecithin organogel as matrix for trans-
dermal transport of drugs.
J. Pharm.
Sci.
,
81
, 871-874.
26.
Ravivarapu, H.B., Moyer, K.L., and
Dunn, R.L. (2000) Sustained suppres-
sion of pituitary-gonadal axis with an
injectable, in situ forming implant of
leuprolide acetate.
J. Pharm. Sci.
,
124
,
14846-14847.
15.
Tiller, J.C. (2003) Increasing the local
concentration of drugs by hydrogel
formation.
Angew. Chem. Int. Ed.
,
42
,
3072-3075.
16.
Yang, Z., Xu, K., Wang, L., Gu, H.,
Wei, H., Zhang, M., and Xu, B. (2005)
Self-assembly of small molecules af-
fords multifunctional supramolecular
hydrogels for topically treating simu-
lated uranium wounds.
Chem. Commun.
(Camb.)
, 4414-4416.
17.
Bhuniya, S., Seo, Y.J., and Kim,
B.H. (2006) (S)-(
+
)-Ibuprofen-based
hydrogelators: an approach toward anti-
inflammatory drug delivery.
Tetrahedron
Lett.
,
47
, 7153-7156.
18.
Saez, J.A., Escuder, B., and Miravet,
J.F. (2010) Supramolecular hydrogels
for enzymatically triggered self-
immolative drug delivery.
Tetrahedron
,
66
89
,
732-741.
27.
Perez-Marrero, R. and Tyler, R.C. (2004)
A subcutaneous delivery system for the
extended release of leuprolide acetate for
the treatment of prostate cancer.
Expert
Opin. Pharmacother.
,
, 447-457.
28.
Sanofi-Aventis Eligard Hormonal
Therapy for Advanced Prostate,
http://www.eligard.com/default.aspx
(accessed 9 December 2011).
29.
Southard, G.L., Dunn, R.L., and Garrett,
S. (1998) The drug delivery and bio-
material attributes of the ATRIGEL
technology in the treatment of periodon-
tal disease.
Expert Opin. Invest. Drugs
,
7
,
1483-1491.
30.
Zila Atridox
http://www.zila.com/36/
atridox%C2%AE/
(accessed 9 December
2011).
31.
Murdan, S., Gregoriadis, G., and
Florence, A.T. (1999) Sorbitan mono-
stearate/polysorbate 20 organogels
containing niosomes: a delivery vehi-
cle for antigens?
Eur. J. Pharm. Sci.
,
8
,
177-185.
32.
Le Renard, P.E., Jordan, O., Faes, A.,
Petri-Fink, A., Hofmann, H., Rufenacht,
D., Bosman, F., Buchegger, F., and
Doelker, E. (2010) The in vivo per-
formance of magnetic particle-loaded
injectable, in situ gelling, carriers for
the delivery of local hyperthermia.
Biomaterials
,
5
, 2614-2618.
19.
Rooseboom, M., Commandeur, J.N.,
and Vermeulen, N.P. (2004) Enzyme-
catalyzed activation of anticancer
prodrugs.
Pharmacol. Rev.
,
, 53-102.
20.
Yang, Z.M., Gu, H.W., Fu, D.G., Gao,
P., Lam, J.K., and Xu, B. (2004) En-
zymatic formation of supramolecular
hydrogels.
Adv. Mater.
,
16
, 1440-1444.
21.
Yang, Z., Liang, G., and Xu, B. (2008)
Enzymatic hydrogelation of small
molecules.
Acc. Chem. Res.
,
41
, 315-326.
22.
Terech, P. and Weiss, R.G. (1997) Low
molecular mass gelators of organic liq-
uids and the properties of their gels.
Chem. Rev.
,
56
, 3133-3160.
23.
Avramiotis, S., Papadimitriou, V.,
Hatzara, E., Bekiari, V., Lianos, P., and
Xenakis, A. (2007) Lecithin organogels
used as bioactive compounds carriers. A
microdomain properties investigation.
Langmuir
,
97
, 691-705.
33.
Gao, Z.-H., Crowley, W.R., Shukla,
A.J., Johnson, J.R., and Reger, J.F.
(1995) Controlled release of contra-
ceptive steroids from biodegradable
and injectable gel formulations: in vivo
evaluation.
Pharm. Res.
,
31
23
, 4438-4447.
24.
Agrawal, V., Gupta, V., Ramteke, S., and
Trivedi, P. (2010) Preparation and eval-
uation of tubular micelles of pluronic
lecithin organogel for transdermal deliv-
ery of sumatriptan.
AAPS PharmSciTech
,
11
, 864-868.
34.
Tokuyama, H. and Kato, Y. (2010)
Preparation of thermosensitive poly-
meric organogels and their drug release
behaviors.
Eur. Polym. J.
,
46
, 277-282.
35.
Lukyanova, L., Franceschi-Messant, S.,
Vicendo, P., Perez, E., Rico-Lattes, I.,
12
, 1718-1725.
25.
Willimann, H., Walde, P., Luisi, P.L.,
Gazzaniga, A., and Stroppolo, F. (1992)
Search WWH ::
Custom Search